Press Release: Global Wellness Signs Definitive Agreement with Cannvalate Australia
Cannabis Law Report
AUGUST 10, 2021
Enters into the Chronic Pain Market with Psychedelics. This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. 2 Pain 1994 Apr;57(1):5-15. billion in 2030.
Let's personalize your content